Everpar Advisors LLC Acquires Shares of 9,925 The Procter & Gamble Company (NYSE:PG)

Everpar Advisors LLC bought a new position in The Procter & Gamble Company (NYSE:PG) in the fourth quarter, HoldingsChannel.com reports. The fund bought 9,925 shares of the company’s stock, valued at approximately $1,454,000. Procter & Gamble makes up approximately 0.7% of Everpar Advisors LLC’s holdings, making the stock its 24th biggest holding.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Naples Money Management LLC acquired a new stake in shares of Procter & Gamble during the fourth quarter worth approximately $29,000. Wyrmwood Management LLC bought a new stake in Procter & Gamble during the 4th quarter worth approximately $29,000. MeadowBrook Investment Advisors LLC acquired a new stake in Procter & Gamble during the 4th quarter valued at $33,000. Criterion Capital Advisors LLC bought a new position in Procter & Gamble in the 4th quarter valued at $33,000. Finally, Pacific Capital Wealth Advisors Inc. acquired a new position in Procter & Gamble in the fourth quarter worth $35,000. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Down 0.4 %

PG traded down $0.71 during mid-day trading on Wednesday, hitting $165.05. The stock had a trading volume of 4,579,411 shares, compared to its average volume of 6,870,830. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $166.37. The firm has a market capitalization of $389.54 billion, a price-to-earnings ratio of 26.97, a price-to-earnings-growth ratio of 3.34 and a beta of 0.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The stock’s fifty day simple moving average is $160.23 and its 200-day simple moving average is $154.49.

Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. During the same period in the previous year, the company posted $1.37 earnings per share. The company’s revenue for the quarter was up .6% on a year-over-year basis. As a group, research analysts forecast that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.44%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble’s dividend payout ratio is presently 65.69%.

Insider Buying and Selling

In other news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the sale, the chief executive officer now directly owns 4,859 shares in the company, valued at $768,256.49. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, CEO Gary A. Coombe sold 21,388 shares of Procter & Gamble stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $164.98, for a total value of $3,528,592.24. Following the sale, the chief executive officer now owns 36,854 shares of the company’s stock, valued at $6,080,172.92. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO R. Alexandra Keith sold 776 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the sale, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at approximately $768,256.49. The disclosure for this sale can be found here. Insiders have sold a total of 140,112 shares of company stock worth $22,841,321 over the last ninety days. Company insiders own 0.17% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on PG. Raymond James lifted their price target on Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a report on Wednesday, January 24th. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. Argus boosted their price objective on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Thursday, April 25th. Finally, Royal Bank of Canada increased their price objective on Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $169.76.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.